top of page
Browse by category
Search


Maintaining weight loss after bariatric surgery more difficult due to fat cells' 'memory' of prediabetes
Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery more difficult, according to new research being presented at the European Congress on Obesity (ECO) in Istanbul, Turkey. "Our findings suggest that prediabetes is associated with persistent changes in fat tissue that may limit its ability to fully adapt after weight loss," said author, Dr Camila Milad from Hospital Clinic de Barce


AI-based monitoring reveals protein deficiencies in people taking GLP-1s
Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, according to one of the first real-world studies to examine dietary behaviour in people using glucagon-like peptide-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual agonists RAs (collectively referred to as GLP-1 RAs) with the help of an AI-pow


J&J’s OTTAVA Robotic Surgical System delivers positive RYGB outcomes
Johnson & Johnson has announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System – a prospective, multi-centre clinical study evaluating the safety and performance of the system in Roux-en-Y gastric bypass (RYGB) procedures. The results were presented at the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting. “The data show encouraging evidence regarding the safety and performance of the OTTAVA™ Robotic


Coffee time interview with Paulina Salminen
Bariatric News spoke with Professor Paulina Salminen, a professor of surgery and gastrointestinal surgery at University of Turku and Turku University Hospital in Finland, and President of the European Chapter of the International Federation For Surgery and Other Therapies for Obesity (IFSO-EC/IFSO), about her career path, her commitment to evidence-based research, and the challenges facing metabolic and bariatric surgery (MBS)... Why did you decide to enter medicine? Initial


Magnetic compression anastomosis – the future of GI surgery
For nearly two decades, Professor Michel Gagner (Professor of Surgery in Montreal, Canada) has been working on new technologies to eliminate the limitations and complications associated with staplers and sutures. His innovative solution is magnetic compression anastomosis. In this interview he discusses the evolution of the technology, the positive outcomes, the latest data to be presented in Malaga and why he believes it could revolutionise the future if gastro-intestinal (G


Improving our understanding of endoscopic sleeve gastroplasty
The British Obesity & Metabolic Specialist Society (BOMSS) recently revealed that endoscopic sleeve gastroplasty (ESG) procedural data will be incorporated into the Society’s National Bariatric Surgery Registry (NBSR). In this interview, Mr Omar Khan, Chair of the NBSR Committee, and Mr Jamie Kelly, who has performed over 500 ESG procedures, discuss the importance of the registry, why ESG plays a crucial role in the armamentarium of a bariatric specialist and the future possi
Browse by tag






bottom of page
